Skip to main content
. 2022 Jun 17;14(12):2992. doi: 10.3390/cancers14122992
ALM acral lentiginous melanoma
AUC area under the curve
BRAF v-Raf murine sarcoma viral oncogene homolog B1
CI confidence interval
CMMR Central Malignant Melanoma Registry
CR complete response
CT computed tomography
CTLA-4 cytotoxic T-lymphocyte-associated protein 4
CV cross-validation
FCBF fast correlation-based filter for feature selection
IQR interquartile range
LDH lactate dehydrogenase
LMM lentigo maligna melanoma
LoG Laplacian of Gaussian
MEK mitogen-activated protein kinase kinase
ML machine learning
mRMR minimum redundancy–maximum relevance feature selection
n number
NM nodular melanoma
OS overall survival
PACS picture archiving and communication system
PD progressive disease
PD-1 programmed death 1
PET positron emission tomography
PFS progression-free survival
PR partial response
RAF rapidly accelerated fibrosarcoma
RAS rat sarcoma
RECIST Response Evaluation Criteria in Solid Tumors
ROC receiver-operating characteristic
SD stable disease
SSM superficial spreading melanoma